Advanced Sterilization Products (ASP), part of the Johnson & Johnson Medical Devices Companies, has announced that the new STERRAD 100NX System with ALLClear Technology is available in the United States and to select customers in Europe, Middle East and Africa (EMEA). Recently cleared by the U.S. Food and Drug Administration, the next-generation system is designed to help Central Sterile Services Departments maximize efficiency and comply with government and facility requirements.
The STERRAD 100NX System with ALLClear Technology is a low-temperature sterilization system that uses proprietary algorithms to minimize workflow interruptions and cycle cancellations. The system includes features that simplify system operation and automatically monitors conditions, providing pre-sterilization cycle load conditioning, load checks and system checks to reduce operator error while improving productivity.
Additionally, it can be paired with ASP ACCESS to automate data sharing across all connected ASP systems and hospital networks, minimizing the need for manual documentation. Systems are currently in use at a select number of hospitals in the United States and Europe. It will be rolled out in Australia, New Zealand, Canada, Latin America and Japan, as well as additional markets in EMEA and Asia Pacific, throughout 2017.
